News
INTEGRATE Advances Lassa Fever Research with Phase 2 of ARN-75039 Trial in Nigeria
Lassa fever, which remains endemic in West Africa, typically surges during the…
Advancing Lassa Fever Research: INTEGRATE features at the 2025 International Conference in Abidjan
Members of the INTEGRATE consortium shared key scientific insights and presented updates…
INTEGRATE CONSORTIUM BUILDS STAFF CAPACITY TO SUPPORT ONGOING CLINICAL TRIAL
AS INCLUSIONS FOR ITS CLINICAL TRIAL FOR A NEW LASSA FEVER TREATMENT…
Revolutionary INTEGRATE clinical trial seeking new Lassa fever treatment starts patient inclusions
In May 2025, the INTEGRATE clinical trial officially started first patient inclusions…
